Managing Partner, Hoffmann & Baron, LLP Featured In ROI-NJ
Daniel A. Scola, Jr., Managing Partner at Hoffmann & Baron, LLP, was recently quoted in an ROI-NJ article by reporter Brett Johnson, where they delved into the evolving process of patenting innovations.
- Newark, NJ (1888PressRelease) December 09, 2023 - Daniel A. Scola, Jr., Managing Partner at Hoffmann & Baron, LLP, was recently quoted in an ROI-NJ article by reporter Brett Johnson, where they delved into the evolving process of patenting innovations.
In the article, Scola discussed the impact predictive analysis has on the patent process. The fast-paced increase in patent innovations task intellectual property attorneys with additional challenges in devising strategic protection plans. The balance of disclosing sufficient information to obtain protection, while avoiding over-disclosure becomes paramount.
Scola described the situation as one that frequently arises in the pharmaceutical industry in New Jersey. Companies in that industry might only have one chemical. However, they can project numerous findings from early studies, including possible new medications, thanks to their advanced technologies.
Scola further detailed that businesses aim to maximize the value of their research. However, he believes that the kinds of safeguards that businesses can obtain through intellectual property claims are being slowly reduced, particularly in the biopharma space. The responsibility is now greater on patent applicants to obtain more data to support the range of protections they desire.
Scola stated, “The way to adjust to it is to not disclose more than you can actually support, and to save that extra portion for when you have data to support it.” Scola believes that this often can result a basic unfairness to patentees.
He further elaborated, “It’s sometimes best to hold back on including certain information in an original patent application. What you should disclose on those applications is a judgment call, because you do want to disclose enough to get good coverage.”
Hoffmann & Baron, LLP, work with a variety of companies from entrepreneurial to global.
To read the article, please click here: https://bit.ly/3uIQutl The article was also reprinted by ‘Invest Money UK.’
To view Hoffmann & Baron media outreach, please click here: https://www.hbiplaw.com/in-the-news/ For more information, contact https://www.hbiplaw.com/contact-us/
ABOUT DAN SCOLA:
Daniel A. Scola, Jr. is the managing partner of Hoffmann & Baron, LLP, and also manages the chemical, pharmaceutical/biochemical and medical device practice group in the New Jersey office. He has extensive experience in polymers, pharmaceuticals and medical devices. He specializes in building IP portfolios and designing strategies to protect and enhance company value. He also practices extensively in Post Grant Proceedings at the USPTO and has argued Post Grant Proceedings at the appellate level, before the CAFC. Previously, he was Counsel, patents, and trademarks as well as Assistant Corporate Secretary at The Warner-Lambert Co. and Intellectual Property Attorney at Loctite Corporation.
Prior to earning his law degree, Scola was a chemist with particular experience in material science including polymers, adhesives and biodegradable approaches to material engineering. He was a scientist at the Pratt & Whitney Division of United Technologies.
ABOUT HOFFMANN & BARON, LLP:
Hoffmann & Baron is a full-service IP law firm specializing in all areas of intellectual property, both domestically and internationally. Their services include IP procurement as well as litigation, counseling, licensing, and post-grant proceedings. With an entrepreneurial spirit, not usually seen in the legal industry, the firm attracts world-class attorneys. For almost four decades, the practice has become known for its unparalleled ability to protect intellectual property and transform ideas into assets.
Hoffmann & Baron, LLP provides cost-effective intellectual property and business strategies tailored to individual client needs to enhance commercial outcomes. Efficiency, discipline and focus on our client’s commercial success are the governing guides. Established in 1984 by co-founders Charles R. Hoffmann and Ronald J. Baron, the firm has offices in New York, New Jersey, and Washington, D.C. The firm is proud to serve clients around the globe in all scientific and engineering fields, from start-ups to Fortune 500 companies, as well as some of the most respected research institutions.
Media Contact:
Amy Delman
Amy Delman Public Relations, LLC
201.563.4614
amydelmanpr ( @ ) verizon dot net
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam